Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020:159:332-343.
doi: 10.1016/j.addr.2020.04.004. Epub 2020 Apr 16.

Extracellular vesicles as drug delivery systems: Why and how?

Affiliations
Free article
Review

Extracellular vesicles as drug delivery systems: Why and how?

Omnia M Elsharkasy et al. Adv Drug Deliv Rev. 2020.
Free article

Abstract

Over the past decades, a multitude of synthetic drug delivery systems has been developed and introduced to the market. However, applications of such systems are limited due to inefficiency, cytotoxicity and/or immunogenicity. At the same time, the field of natural drug carrier systems has grown rapidly. One of the most prominent examples of such natural carriers are extracellular vesicles (EVs). EVs are cell-derived membranous particles which play important roles in intercellular communication. EVs possess a number of characteristics that qualify them as promising vehicles for drug delivery. In order to take advantage of these attributes, an in-depth understanding of why EVs are such unique carrier systems and how we can exploit their qualities is pivotal. Here, we review unique EV features that are relevant for drug delivery and highlight emerging strategies to make use of those features for drug loading and targeted delivery.

Keywords: Drug delivery; Engineering; Exosomes; Extracellular vesicles; Isolation; Nanomedicine; Safety; Targeting; Upscaling.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest J.Z.N. is consultant for and has equity interests in Evox Therapeutics Ltd. R.M.S. is CSO of Excytex bv. S.EL.A. is co-founder and shareholder in Evox Therapeutics. P.V. serves on the scientific advisory board of Evox Therapeutics.

Publication types

LinkOut - more resources